Latest
Pharma shakeups put pressure on top brass at Amgen to perform
With activist investor Bill Ackman pushing to buy Botox maker Allegran in a bid with upstart Valeant and restructurings under way at pharma giants GlaxoSmithKline, Eli Lilly & Co. and Novartis, it’s logical to question whether biotech giant Amgen will be next. So far the answer seems to be “not yet” — with one big Read More →
Latest
Amgen pays $290M to exit osteoporosis drug deal
Amgen will pay $290 million to end its collaboration with British drugmaker GlaxoSmithKline to commercialize the osteoporosis drug denosumab in certain markets outside the U.S.
Latest
Amgen Tour includes Pismo Beach, Cambria as first-time host cities
The two cities will play a part in highlighting the beauty of the Central Coast during the 740-mile cycling stage race, which will begin May 11.
